Do not ingest, inject, reconstitute, or otherwise administer
This article does not constitute medical advice
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) Small-molecule NNMT inhibitor often discussed with metabolic protocols
Rodrguez Cetina Biefer H, et al
This is problematic because muscle mass contributes to metabolic rate, functional capacity, and long-term health
Our patients should achieve optimal outcomes, and we aim to optimize their weight loss, nutrition, and peptides as needed, while creating an ideal healing environment with reduced scarring and improved outcomes